TABLE 9. Estimated percent using an inhaled corticosteroid in the past 3 months among children1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2006-2010
State/Territory
Current
Active
Sample
size±
%
SE§
95% CI†
Sample
size
%
SE
95% CI
Arizona
125
25.9
6.0
(14.1 – 37.7)
149
23.4
5.3
(13.0 – 33.8)
California
170
28.0
4.4
(19.4 – 36.6)
206
23.9
3.6
(16.8 – 31.0)
Connecticut
347
26.8
3.0
(20.9 – 32.7)
413
23.2
2.6
(18.1 – 28.3)
District of Columbia
114
25.5
4.5
(16.7 – 34.3)
140
23.3
3.9
(15.7 – 30.9)
Georgia
341
24.6
3.2
(18.3 – 30.9)
399
22.0
2.8
(16.5 – 27.5)
Hawaii
417
20.0
2.6
(14.9 – 25.1)
444
19.8
2.4
(15.1 – 24.5)
Illinois
168
25.8
4.4
(17.2 – 34.4)
196
22.8
3.9
(15.2 – 30.4)
Indiana
348
30.2
3.2
(23.9 – 36.5)
391
25.8
2.9
(20.1 – 31.5)
Iowa
249
20.0
2.9
(14.3 – 25.7)
274
17.8
2.6
(12.7 – 22.9)
Kansas
588
32.1
2.3
(27.6 – 36.6)
657
29.3
2.1
(25.2 – 33.4)
Louisiana
107
19.0
4.1
(11.0 – 27.0)
122
17.1
3.7
(9.8 – 24.4)
Maine
284
34.8
3.3
(28.3 – 41.3)
332
30.1
3.0
(24.2 – 36.0)
Maryland
385
21.7
2.5
(16.8 – 26.6)
467
17.8
2.1
(13.7 – 21.9)
Massachusetts
269
31.7
4.1
(23.7 – 39.7)
315
27.6
3.7
(20.3 – 34.9)
Michigan
480
30.5
2.8
(25.0 – 36.0)
533
28.7
2.6
(23.6 – 33.8)
Mississippi
80
21.4
6.2
(9.2 – 33.6)
94
18.3
5.4
(7.7 – 28.9)
Missouri
230
31.6
4.4
(23.0 – 40.2)
255
28.3
4.2
(20.1 – 36.5)
Montana
210
28.4
3.9
(20.8 – 36.0)
253
26.0
3.5
(19.1 – 32.9)
Nebraska
467
30.2
3.7
(22.9 – 37.5)
528
27.8
3.4
(21.1 – 34.5)
New Hampshire
150
26.3
4.1
(18.3 – 34.3)
173
23.6
3.7
(16.3 – 30.9)
New Jersey
296
21.7
3.2
(15.4 – 28.0)
337
19.5
3.0
(13.6 – 25.4)
New Mexico
234
21.5
3.8
(14.1 – 28.9)
262
19.5
3.4
(12.8 – 26.2)
New York
276
23.3
3.3
(16.8 – 29.8)
336
19.2
2.7
(13.9 – 24.5)
North Dakota
98
25.4
5.4
(14.8 – 36.0)
120
19.6
4.6
(10.6 – 28.6)
Ohio
222
25.3
4.4
(16.7 – 33.9)
258
21.1
3.8
(13.7 – 28.5)
Oklahoma
250
32.1
3.5
(25.2 – 39.0)
256
31.7
3.5
(24.8 – 38.6)
Oregon
193
19.6
2.9
(13.9 – 25.3)
224
18.5
2.7
(13.2 – 23.8)
Pennsylvania
134
28.2
4.7
(19.0 – 37.4)
156
23.9
4.0
(16.1 – 31.7)
Rhode Island
153
32.6
4.2
(24.4 – 40.8)
180
30.2
3.8
(22.8 – 37.6)
Texas
479
27.6
3.3
(21.1 – 34.1)
558
23.2
2.9
(17.5 – 28.9)
Utah
368
30.6
3.8
(23.2 – 38.0)
414
28.9
3.5
(22.0 – 35.8)
Vermont
389
36.0
2.8
(30.5 – 41.5)
443
33.1
2.7
(27.8 – 38.4)
Virginia
88
35.7
8.7
(18.6 – 52.8)
100
33.7
8.1
(17.8 – 49.6)
Washington
341
23.7
2.9
(18.0 – 29.4)
389
22.8
2.9
(17.1 – 28.5)
West Virginia
193
22.2
3.4
(15.5 – 28.9)
213
20.1
3.1
(14.0 – 26.2)
Wisconsin
147
28.6
4.8
(19.2 – 38.0)
206
22.2
3.7
(14.9 – 29.5)
36 state total
9,390
26.8
1.0
(24.8 – 28.8)
10,793
23.4
0.9
(21.6 – 25.2)
Median
26.6
23.3
Range
19.0-36.0
17.1-33.7
1 Aged < 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Sample size is for multiple years of participation. Responses of “Don’t Know” and “Refused” are excluded.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.